Welcome from the Chair
8th Symmetry Webinar
Advances in Catalytic Asymmetric Synthesis
Asymmetric Synthesis is perhaps the most challenging endeavor in Organic Synthesis as it enables the selective construction of single enantiomers of chiral compounds. The increasing importance and array of applications of chiral small molecules and higher molecular architectures in Material Science and Medicine (>40% of approved drugs are single enantiomers) has been a constant drive for expanding our capabilities in Asymmetric Synthesis. In this context, Asymmetric Catalysis has emerged as a powerful tool in synthesizing chiral compounds in high optical purity and in an economical, efficient, “green” and controlled manner. In addition, the development of new Catalytic Asymmetric methodologies enables the training of young organic chemists into 3D thinking/visualization, consideration of competing diastereoisomeric transition states, understating the origins of asymmetric induction and enantioselectivity and ultimately catalyst design encompassing metal complexes, small organic molecules and macromolecular biocatalysts.
Date: 5 September 2022
Time: 10:00 am CEST | 4:00 am EDT | 4:00 pm CST Asia
Webinar ID: 858 7050 2130
Webinar Secretariat: firstname.lastname@example.org
Department of Chemistry, University of Patras, Greece
Gerry Rassias graduated with a First Class Chemistry degree (BSc Hons) in 1995 from the University of Liverpool where he also started his doctoral research under the supervision of Prof. Phillip C. B. Page on “New systems for catalytic asymmetric epoxidation” using iminium salt-organocatalysts. He concluded his doctorate work at Loughborough University in 1998 due to the appointment of Prof. Phil C. P. Page as Head of Organic Chemistry at the latter institution and stayed with Prof. Phil C. P. Page for his first post-doctoral appointment where he worked towards the total synthesis of lactacystin and novel chiral ligands for palladium-catalysed asymmetric transformations. After mandatory military service in Greece Gerry joined the group of Prof. K. C. Nicolaou at The Scripps Research Institute, La Jolla, USA, as a postdoctoral fellow where he worked on the total synthesis of diazonamide A and analogues of epothilone B. In April 2003. Gerry joined GlaxoSmithKline’s Chemical Development at Stevenage, UK and for the next 10 years worked on several GSK drug development projects. Gerry was the lead chemist in the chemical development of trametinib for the treatment of melanoma and authored parts of the file that was approved by the FDA. In October 2012 Gerry joined the Chemistry Department of the University of Patras and his research interests span Synthetic Methodology, Green Chemistry, Medicinal Chemistry, Asymmetric catalysis, and Process Development
Department of Chemistry, University of Basel, Switzerland
Olivier Baudoin was educated at the Ecole National Superieure de Chimie in Paris, and obtained his PhD degree in 1998 under the supervision of Jean-Marie Lehn and Marie-Paule Teulade-Fichou at College de France, Paris. After a post-doctoral stay with K. C. Nicolaou at Scripps Research Institute, La Jolla, he became a group leader in CNRS in 1999 at the Institut de Chimie des Substances Naturelles, Gif-sur-Yvette. In 2006, he moved to the University of Lyon as a Professor, where he stayed until 2015. Since then, he has been a Full Professor in chemistry at the University of Basel. His main research interests are in transition-metal-catalyzed C-H bond functionalization and the application to the synthesis of functional molecules.
School of Physical and Chemical Sciences, Queen Mary University of London, UK
Stellios was born in Athens (Greece) in 1975 and studied chemistry at Université Paris XI. In 1999, then moved to Université Louis Pasteur in Strasbourg where he did his PhD under the guidance of Dr C. Mioskowski. In 2001, Stellios joined Rhodia Chirex Inc. (Boston, USA) for 18 months during which I worked on various palladium- and copper-catalyzed aryl bond formation processes in collaboration with Prof. S. L. Buchwald (MIT). After a first postdoc with Prof. A. C. Spivey at Imperial College (London, UK) working in the field of asymmetric organocatalysis, Stellios joined Prof. K. C. Nicolaou’s group at The Scripps Research Institute (La Jolla, USA). There, he was involved in the synthesis of new epothilone B analogues and on the total synthesis of vannusal A. In 2005, he joined the CNRS as a permanent researcher in the group of Prof. J. Cossy (ESPCI, Paris, France) and was promoted to Director in 2015. The same year, I accepted a Reader position at Queen Mary University of London. My group is interested in developing new synthetic tools and applying them to the synthesis of natural products and other biologically active frameworks.
Ecole Nationale Supérieure de Chimie de Montpellier, France
Jean-Marc Campagne received his Ph.D. at the University of Montpellier in 1994. After post-doctoral training with Prof B. Trost (Stanford University, USA) and Prof. L. Ghosez (Université Catholique de Louvain, Belgium), he was appointed CNRS researcher at the Institut de Chimie des Substances Naturelles in Gif-sur-Yvette in 1998. In 2005 he moved to the Ecole Nationale Supérieure de Chimie de Montpellier where he was appointed Professor. His current interests concern the development of catalytic asymmetric transformations and their application to the total synthesis of natural products.
This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.
Time in CEST
Chair Prof. Gerry Rassias
10:00 - 10:05 am
Prof. Dr. Olivier Baudoin
Pd(0)-Catalyzed Enantioselective C–H Activation
10:05 - 10:40 am
Prof. Dr. Stellios Arseniyadis
Innovative DNA-based Asymmetric Catalysis
10:40 - 11:15 am
Prof. Dr. Jean-Marc Campagne
Iron-Catalyzed Enantioselective Intramolecular Inverse Electron-Demand Hetero-Diels-Alder Reactions
11:15 - 11:50 am
Prof. Gerry Rassias
Organocatalytic Asymmetric Halocyclisation of N-Allylic Amides
11:50 am – 12:25 pm
Closing of Webinar
Chair Prof. Gerry Rassias
12:25 – 12:30 pm
Novel Approaches for Asymmetric Synthesis
Guest Editors: Dr. Veroniki Peter Vidali, Dr. Marina Sagnou & Dr. Gerasimos Rassias
Deadline for manuscript submissions: 16 January 2023
Symmetry/Asymmetry Applied in Chemical Synthesis
Guest Editors: Prof. Dr. Mingyou Hu and Dr. Le Liu
Deadline for manuscript submissions: 30 September 2022
New Frontiers in Asymmetric Organocatalysis
Guest Editors: Dr. Fabrizio Vetica and Prof. Dr. Jesús F. Arteaga
Deadline for manuscript submissions: 31 March 2023
Symmetry and Asymmetry in Medicinal Chemistry
Guest Editor: Prof. Dr. Josef Jampilek
Deadline for manuscript submissions: 30 December 2022